Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A2/prostaglandin E2 content
暂无分享,去创建一个
Wei Cui | Qinwen Wang | Yanfei Ding | Yuanyuan Wang | Xiaoming Bao | Jieyi Shentu | Xiaowei Chen | Xiaofei Wei | Shujun Xu
[1] I. Módy,et al. Rosiglitazone prevents the memory deficits induced by amyloid-beta oligomers via inhibition of inflammatory responses , 2014, Neuroscience Letters.
[2] E. Hamel,et al. Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization , 2017, Scientific Reports.
[3] R. Anwyl,et al. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5 , 2004, The Journal of Neuroscience.
[4] K. Irie,et al. Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues* , 2013, Journal of Biological Chemistry.
[5] H. Nakanishi,et al. The Neuroprotective Effects of Brazilian Green Propolis on Neurodegenerative Damage in Human Neuronal SH-SY5Y Cells , 2017, Oxidative medicine and cellular longevity.
[6] S. Alwasel,et al. Antioxidant activity of taxifolin: an activity–structure relationship , 2016, Journal of enzyme inhibition and medicinal chemistry.
[7] Jin-Tai Yu,et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.
[8] H. Koch,et al. Prostaglandin E2-Induced Synaptic Plasticity in Neocortical Networks of Organotypic Slice Cultures , 2010, The Journal of Neuroscience.
[9] A. Velayati,et al. Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial , 2016, Iranian journal of pharmaceutical research : IJPR.
[10] Gaiping Li,et al. A simple and sensitive method for determination of taxifolin on palladium nanoparticles supported poly (diallyldimethylammonium chloride) functionalized graphene modified electrode. , 2017, Talanta.
[11] K. Irie,et al. Structure–Activity Relationship for (+)-Taxifolin Isolated from Silymarin as an Inhibitor of Amyloid β Aggregation , 2013, Bioscience, biotechnology, and biochemistry.
[12] Ping Yang,et al. Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MSn , 2016, Molecules.
[13] A. Besmehn,et al. The amyloid-β oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[14] Á. Simonyi,et al. Role of Cytosolic Phospholipase A2 in Oxidative and Inflammatory Signaling Pathways in Different Cell Types in the Central Nervous System , 2014, Molecular Neurobiology.
[15] G. Valacchi,et al. Potassium Ascorbate with Ribose: Promising Therapeutic Approach for Melanoma Treatment , 2017, Oxidative medicine and cellular longevity.
[16] Shaomin Li,et al. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number. , 2014, Journal of Alzheimer's disease : JAD.
[17] Alun Williams,et al. α-Synuclein-Induced Synapse Damage in Cultured Neurons Is Mediated by Cholesterol-Sensitive Activation of Cytoplasmic Phospholipase A2 , 2015, Biomolecules.
[18] K. Jellinger,et al. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.
[19] P. Mcgeer,et al. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. , 2008, Journal of Alzheimer's disease : JAD.
[20] S. Lesné,et al. Soluble Aβ oligomer production and toxicity , 2012, Journal of neurochemistry.
[21] O. Arancio,et al. Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach , 2015, Neurotherapeutics.
[22] J. Cirrito,et al. Genetic Modulation of Soluble Aβ Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease , 2014, The Journal of Neuroscience.
[23] Yifan Han,et al. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway , 2016, Molecular Neurobiology.
[24] B. Hyman,et al. Alzheimer's disease: synapses gone cold , 2011, Molecular Neurodegeneration.
[25] Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology , 2014, Molecular Neurodegeneration.
[26] Alun Williams,et al. Phospholipase A2 inhibitors protect against prion and Aβ mediated synapse degeneration , 2010, Molecular Neurodegeneration.
[27] J. Pérez-Ortín,et al. Cytoplasmic 5′-3′ exonuclease Xrn1p is also a genome-wide transcription factor in yeast , 2013, Front. Genet..
[28] Anne Corbett,et al. Alzheimer's disease , 2011, The Lancet.
[29] J. Bryan,et al. Janus Kinase 3 Activity Is Necessary for Phosphorylation of Cytosolic Phospholipase A2 and Prostaglandin E2 Synthesis by Macrophages Infected with Francisella tularensis Live Vaccine Strain , 2013, Infection and Immunity.
[30] Alun Williams,et al. cAMP-Inhibits Cytoplasmic Phospholipase A2 and Protects Neurons against Amyloid-β-Induced Synapse Damage , 2015, Biology.
[31] M. Albert. Changes in cognition , 2011, Neurobiology of Aging.
[32] T. Wyss-Coray,et al. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. , 2012, Cold Spring Harbor perspectives in medicine.
[33] Michael Crossley,et al. Effects of Aβ exposure on long-term associative memory and its neuronal mechanisms in a defined neuronal network , 2015, Scientific Reports.
[34] C. Kim,et al. Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways , 2016, PloS one.
[35] W. Wildering,et al. Phospholipase A2 – nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment , 2014, Front. Genet..
[36] Josiah R. Boivin,et al. Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain , 2017, Molecular Neurodegeneration.